Brind.

Amgen product performance update driven by market access and volume growth in the US.

1 report, 1 independent Updated Aug 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen

How it developed

Newest first. Tap a step to see who reported it.

Jun 7Robert A. Bradway led Amgen's strong performance in August 2025.Sub-event
Aug 8Improved access in the US drove Repatha volume growth and solid sales for Evenity on Aug 8, 2025.1 source
- Zacks

Keep exploring

The entities involved

Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05

Coverage

Newest first; wire copies grouped

Aug 8ZacksAmgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season Amgen AMGN delivered yet another strong quarterly performance. Its second-quarter 2025 earnings and sales beat estimates. The comp